The study aims to identify individuals with mutations in Parkinson's disease-associated genes for further analysis.
NPR reports on a clinical trial examining an antisense oligonucleotide drug for Huntington's disease.
CNN reports on Stanford University's Ron Davis' quest to study chronic fatigue syndrome.
In PLOS this week: profile of a yeast mycoparasite, biology of complex diseases, and more.
A pair of new studies evaluated the effectiveness of cytologic and HPV-based testing approaches at varied screening intervals for identifying women at risk of cervical cancer.
A speaker at this year's Biology of Genomes meeting discussed marrying genomics approaches such as CRISPR and single-cell sequencing to study disease causality.
Baylor Genetics will be King Faisal Specialist Hospital International's exclusive lab partner for all genetic testing and precision medicine applications.
The company is seeing increasing interest in its GeoMx platform with numerous studies from early users presented last month at AACR.
The company also announced that its board of directors has authorized payment of a quarterly cash dividend of $0.04 per share of its common stock.
The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.
An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.
The US Department of Agriculture presents a new blueprint for animal genomic research.
In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.